22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › FULCRUM THERAPEUTICS INC. › 2024-2025

FULCRUM THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and FULCRUM THERAPEUTICS INC.’s Form 8-K, filed June 27, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 6Reported items
  • 125Asset managers, any item
  • 968Fund votes
  • June 26, 2025Meeting date

Results at a glance

Meeting of June 26, 2025: 5 items on FULCRUM THERAPEUTICS INC.’s Form 8-K, filed June 27, 2025: 2 approved · 3 passed (calculated).

Dissent

Significant dissent: 1 director (28.2% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2024-2025 2025-2026

Activist investors: Tang Capital (13F, 9.3%, as of September 30, 2026) · Nantahala Capital (13F, 8.6%, as of September 30, 2026)

Explore FULCRUM THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by FULCRUM THERAPEUTICS INC.

These tallies are FULCRUM THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 27, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

FULCRUM THERAPEUTICS INC. — official shareholder meeting results, meeting held June 26, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Katina Dorton 44,618,582---- 1,601,4893,317,555 97%Passed (calculated)—
Elect Director: Robert J. Gould 43,847,378---- 2,372,6933,317,555 95%Passed (calculated)—
Elect Director: Kate Haviland 33,203,495---- 13,016,5763,317,555 72%Passed (calculated)—
Fulcrum's stockholders approved, on a non-binding advisory basis, the compensation of Fulcrum's named executive officers. 46,099,800111,9678,304 --3,317,555 99.8%Approved—
Fulcrum's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2025. The results of the stockholders' vote with respect to such ratification are 49,513,19022,8081,628 --0 99.9%Approved—

Source: FULCRUM THERAPEUTICS INC., Form 8-K, filed with the SEC on June 27, 2025 — read the filing on EDGAR.

How asset managers voted at the FULCRUM THERAPEUTICS INC. 2024-2025 meeting

125 asset managers disclosed a vote on at least one FULCRUM THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of FULCRUM THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

Elect Director: Kate Haviland

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 2 wordings of this item as funds reported it.

72% Majority: yes · of votes cast

FOR 72%WITHHELD
FOR: 33,203,495WITHHELD: 13,016,576
Details: description as filed, official tally, votes by 42 asset managers

Description as filed by funds: Election Class III Directors, nominated by our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Kate Haviland

FULCRUM THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kate Haviland”): 33,203,495 for, 13,016,576 withheld, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 72% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 42 asset managers below reported 1,436,899 for, 6,420,594 withheld.

FORWITHHOLD
FOR: 1,436,899WITHHOLD: 6,420,594
Largest asset managers voting on “Election Class III Directors, nominated by our Board of Directors, each to serve for a three-year term expirin” at FULCRUM THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard00 03,265,334Withhold
BlackRock173,0980 01,634,588Mixed
Fidelity1,082,6550 045,000For
Charles Schwab00 0383,951Withhold
Aberdeen00 0228,320Withhold
Equitable00 0168,411Withhold
TIAA152,9920 00For
American Century00 0124,902Withhold
QUANTITATIVE MASTER SERIES LLC00 0108,026Withhold
Goldman Sachs00 065,323Withhold
Lincoln Financial00 048,242Withhold
Invesco00 045,343Withhold
Northern Trust00 040,161Withhold
Global X00 031,932Withhold
AIG/SunAmerica00 028,209Withhold
Pacific Life00 023,865Withhold
John Hancock00 022,562Withhold
Bridge Builder Trust00 021,498Withhold
MASTER INVESTMENT PORTFOLIO19,0020 00For
Voya00 018,548Withhold
PACE SELECT ADVISORS TRUST00 016,282Withhold
Jackson National00 014,631Withhold
Prudential/PGIM00 011,430Withhold
ProShares00 010,775Withhold
AQR00 010,274Withhold

Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).

Elect Director: Katina Dorton

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 44,618,582WITHHELD: 1,601,489
Details: description as filed, official tally, votes by 42 asset managers

Description as filed by funds: Election Class III Directors, nominated by our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Katina Dorton

FULCRUM THERAPEUTICS INC.’s own tally for this item (“Elect Director: Katina Dorton”): 44,618,582 for, 1,601,489 withheld, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 42 asset managers below reported 7,750,334 for, 107,159 withheld.

FOR
FOR: 7,750,334WITHHOLD: 107,159
Largest asset managers voting on “Election Class III Directors, nominated by our Board of Directors, each to serve for a three-year term expirin” at FULCRUM THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,265,3340 00For
BlackRock1,807,6860 00For
Fidelity1,127,6550 00For
Charles Schwab383,9510 00For
Aberdeen228,3200 00For
Equitable98,5210 069,890Mixed
TIAA152,9920 00For
American Century124,9020 00For
QUANTITATIVE MASTER SERIES LLC108,0260 00For
Goldman Sachs65,3230 00For
Lincoln Financial38,2000 010,042Mixed
Invesco45,3430 00For
Northern Trust40,1610 00For
Global X31,9320 00For
AIG/SunAmerica28,2090 00For
Pacific Life23,8650 00For
John Hancock22,5620 00For
Bridge Builder Trust21,4980 00For
MASTER INVESTMENT PORTFOLIO19,0020 00For
Voya18,5480 00For
PACE SELECT ADVISORS TRUST16,2820 00For
Jackson National00 014,631Withhold
Prudential/PGIM00 011,430Withhold
ProShares10,7750 00For
AQR10,2740 00For

Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).

Elect Director: Robert J. Gould

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 3 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 43,847,378WITHHELD: 2,372,693
Details: description as filed, official tally, votes by 42 asset managers

Description as filed by funds: Election Class III Directors, nominated by our Board of Directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders: Robert J. Gould

FULCRUM THERAPEUTICS INC.’s own tally for this item (“Elect Director: Robert J. Gould”): 43,847,378 for, 2,372,693 withheld, per its Form 8-K filed June 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 42 asset managers below reported 7,706,625 for, 150,868 withheld.

FOR
FOR: 7,706,625WITHHOLD: 150,868
Largest asset managers voting on “Election Class III Directors, nominated by our Board of Directors, each to serve for a three-year term expirin” at FULCRUM THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,265,3340 00For
BlackRock1,807,6860 00For
Fidelity1,127,6550 00For
Charles Schwab383,9510 00For
Aberdeen228,3200 00For
Equitable98,5210 069,890Mixed
TIAA152,9920 00For
American Century124,9020 00For
QUANTITATIVE MASTER SERIES LLC108,0260 00For
Goldman Sachs65,3230 00For
Lincoln Financial00 048,242Withhold
Invesco45,3430 00For
Northern Trust40,1610 00For
Global X31,9320 00For
AIG/SunAmerica28,2090 00For
Pacific Life23,8650 00For
John Hancock22,5620 00For
Bridge Builder Trust21,4980 00For
MASTER INVESTMENT PORTFOLIO19,0020 00For
Voya18,5480 00For
PACE SELECT ADVISORS TRUST16,2820 00For
Jackson National00 014,631Withhold
Prudential/PGIM00 011,430Withhold
ProShares10,7750 00For
AQR10,2740 00For

Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).

Fulcrum's stockholders approved, on a non-binding advisory basis, the compensation of Fulcrum's named executive…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

99.8% Approved · of votes cast

FOR 99.8%
FOR: 46,099,800AGAINST: 111,967
Details: description as filed, official tally, votes by 125 asset managers

Description as filed by funds: A non-binding advisory vote on executive compensation;

FULCRUM THERAPEUTICS INC.’s own tally for this item (“Fulcrum's stockholders approved, on a non-binding advisory basis, the compensation of Fulcrum's named executive officers.”): 46,099,800 for, 111,967 against — passed, per its Form 8-K filed June 27, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “b) Fulcrum's stockholders approved, on a non-binding advisory basis, the compensation of Fulcrum's named executive officers.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 43 asset managers voting on “A non-binding advisory vote on executive compensation;” at FULCRUM THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,265,3340 00For
BlackRock1,807,6860 00For
Fidelity1,127,6550 00For
Charles Schwab383,9510 00For
Aberdeen228,3200 00For
Equitable168,4110 00For
TIAA152,9920 00For
American Century124,9020 00For
QUANTITATIVE MASTER SERIES LLC108,0260 00For
Simplify Exchange Traded Funds80,2940 00For
Goldman Sachs65,3230 00For
Lincoln Financial48,2420 00For
Invesco45,3430 00For
Northern Trust40,1610 00For
Global X31,9320 00For
AIG/SunAmerica28,2090 00For
Pacific Life23,8650 00For
John Hancock22,5620 00For
Bridge Builder Trust21,4980 00For
MASTER INVESTMENT PORTFOLIO19,0020 00For
Voya18,5480 00For
PACE SELECT ADVISORS TRUST16,2820 00For
Jackson National14,6310 00For
Prudential/PGIM11,4300 00For
ProShares10,7750 00For

Fund voting reports, all 43 managers: 7,936,621 for, 1,166 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 98 asset managers voting on “A non-binding advisory vote on executive compensation;” at FULCRUM THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
RA CAPITAL MANAGEMENT, L.P.9,332,7190 00For
TCG Crossover Management, LLC5,250,0000 00For
SUVRETTA CAPITAL MANAGEMENT, LLC5,223,8790 00For
Nantahala Capital Management, LLC4,306,4730 00For
ADAGE CAPITAL PARTNERS GP, L.L.C.2,376,5280 00For
BlackRock1,729,0210 00For
GEODE CAPITAL MANAGEMENT, LLC1,217,6030 00For
Woodline Partners LP897,6170 00For
State Street880,1190 00For
Exome Asset Management LLC622,8870 00For
BESSEMER TRUST Co NATIONAL ASSOCIATION574,9510 00For
ADAR1 Capital Management, LLC447,6730 00For
Charles Schwab383,9510 00For
DE Shaw355,1930 00For
Bessemer Trust CO of Delaware, N.A.292,7600 00For
BESSEMER TRUST CO289,2370 00For
BESSEMER TRUST Co OF FLORIDA289,2370 00For
Bessemer Trust Co of Nevada, National Association289,2370 00For
Northern Trust253,9630 00For
Aberdeen228,3200 00For
Citadel223,6230 00For
Catalio Capital Management, LP188,3040 00For
Dimensional187,4640 00For
Nuveen152,9920 00For
MELLON INVESTMENTS Corp151,3470 00For

Institutional-manager reports, all 98 managers: 37,645,584 for, 17,917 against, 24,025 1 year. Showing the 25 largest; every one is in the interactive database (link above).

Non-binding advisory vote on the frequency of future executive compensation advisory votes; and

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

99% Fund and manager reports combined; may count the same shares twice · no official result

1 YEAR
Details: description as filed, votes by 116 asset managers

Description as filed by funds: A non-binding advisory vote on the frequency of future executive compensation advisory votes; and

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 42 asset managers voting on “A non-binding advisory vote on the frequency of future executive compensation advisory votes; and” at FULCRUM THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard00 00--
BlackRock00 00--
Fidelity00 00--
Charles Schwab00 00--
Aberdeen00 00--
Equitable00 00--
TIAA00 00--
American Century00 00--
QUANTITATIVE MASTER SERIES LLC00 00--
Goldman Sachs00 00--
Lincoln Financial00 00--
Invesco00 00--
Northern Trust00 00--
Global X00 00--
AIG/SunAmerica00 00--
Pacific Life00 00--
John Hancock00 00--
Bridge Builder Trust00 00--
MASTER INVESTMENT PORTFOLIO00 00--
Voya00 00--
PACE SELECT ADVISORS TRUST00 00--
Jackson National00 00--
Prudential/PGIM00 00--
ProShares00 00--
AQR00 00--

Fund voting reports, all 42 managers: 7,821,390 1 year, 36,103 3 year. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 91 asset managers voting on “A non-binding advisory vote on the frequency of future executive compensation advisory votes; and” at FULCRUM THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
RA CAPITAL MANAGEMENT, L.P.00 00--
SUVRETTA CAPITAL MANAGEMENT, LLC00 00--
BlackRock00 00--
GEODE CAPITAL MANAGEMENT, LLC00 00--
Woodline Partners LP00 00--
State Street00 00--
BESSEMER TRUST Co NATIONAL ASSOCIATION00 00--
ADAR1 Capital Management, LLC00 00--
Charles Schwab00 00--
DE Shaw00 00--
Bessemer Trust CO of Delaware, N.A.00 00--
BESSEMER TRUST CO00 00--
BESSEMER TRUST Co OF FLORIDA00 00--
Bessemer Trust Co of Nevada, National Association00 00--
Northern Trust00 00--
Aberdeen00 00--
Citadel00 00--
Dimensional00 00--
Nuveen00 00--
MELLON INVESTMENTS Corp00 00--
FIDUCIARY TRUST CO00 00--
JACOBS LEVY EQUITY MANAGEMENT, INC00 00--
American Century00 00--
Two Sigma00 00--
Matisse Capital00 00--

Institutional-manager reports, all 91 managers: 27,134 for, 386 against, 24,665,541 1 year, 187,464 3 year. Showing the 25 largest; every one is in the interactive database (link above).

Fulcrum's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm…

Official resultAUDIT-RELATEDReported outcome: Approved

99.9% Approved · of votes cast

FOR 99.9%
FOR: 49,513,190AGAINST: 22,808

Prior year: 100.0% for (June 17, 2024 meeting) unchanged

Details: description as filed, official tally, votes by 42 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

FULCRUM THERAPEUTICS INC.’s own tally for this item (“Fulcrum's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2025. The results of the stockholders' vote with respect to ”): 49,513,190 for, 22,808 against — passed, per its Form 8-K filed June 27, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Fulcrum's stockholders ratified the selection of Ernst & Young LLP as its independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 42 asset managers below reported 7,856,327 for, 1,166 against.

FOR
FOR: 7,856,327AGAINST: 1,166
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ” at FULCRUM THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard3,265,3340 00For
BlackRock1,807,6860 00For
Fidelity1,127,6550 00For
Charles Schwab383,9510 00For
Aberdeen228,3200 00For
Equitable168,4110 00For
TIAA152,9920 00For
American Century124,9020 00For
QUANTITATIVE MASTER SERIES LLC108,0260 00For
Goldman Sachs65,3230 00For
Lincoln Financial48,2420 00For
Invesco45,3430 00For
Northern Trust40,1610 00For
Global X31,9320 00For
AIG/SunAmerica28,2090 00For
Pacific Life23,8650 00For
John Hancock22,5620 00For
Bridge Builder Trust21,4980 00For
MASTER INVESTMENT PORTFOLIO19,0020 00For
Voya18,5480 00For
PACE SELECT ADVISORS TRUST16,2820 00For
Jackson National14,6310 00For
Prudential/PGIM11,4300 00For
ProShares10,7750 00For
AQR10,2740 00For

Showing the 25 largest of 42 asset managers. All 42 are in the interactive database (link above).

Largest FULCRUM THERAPEUTICS INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 53,979,306 shares outstanding at the time of that meeting.

Fund voting reports: top FULCRUM THERAPEUTICS INC. shareholders by shares voted on “A non-binding advisory vote on executive compensation;”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 6.05%
2BlackRock 3.35%
3Fidelity 2.09%
4Charles Schwab 0.71%
5Aberdeen 0.42%
6Equitable 0.31%
7TIAA 0.28%
8American Century 0.23%
9QUANTITATIVE MASTER SERIES LLC 0.20%
10Simplify Exchange Traded Funds 0.15%
Institutional-manager reports: top FULCRUM THERAPEUTICS INC. shareholders by shares voted on “A non-binding advisory vote on executive compensation;”, 2024-2025
#Asset manager % of shares outstanding
1RA CAPITAL MANAGEMENT, L.P. 17.29%
2TCG Crossover Management, LLC 9.73%
3SUVRETTA CAPITAL MANAGEMENT, LLC 9.68%
4Nantahala Capital Management, LLC 7.98%
5ADAGE CAPITAL PARTNERS GP, L.L.C. 4.40%
6BlackRock 3.20%
7GEODE CAPITAL MANAGEMENT, LLC 2.26%
8Woodline Partners LP 1.66%
9State Street 1.63%
10Exome Asset Management LLC 1.15%

Reported FULCRUM THERAPEUTICS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

FULCRUM THERAPEUTICS INC. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
RA Capital Management, L.P.10,229,099 18.95%Proxy statement (DEF 14A), proxy filed April 30, 2025
TCG Crossover GP II, LLC5,250,000 9.73%Schedule 13G, filed May 15, 2026
BlackRock4,710,697 8.73%Form 13F, quarter ended March 31, 2025
Suvretta Capital Management, LLC3,404,612 6.31%Proxy statement (DEF 14A), proxy filed April 30, 2025
Vanguard Group3,220,378 5.97%Form 13F, quarter ended March 31, 2025
Nantahala Capital Management, LLC3,050,040 5.65%Schedule 13G, filed May 15, 2026
Adage Capital Partners GP, LLC.3,000,000 5.56%Proxy statement (DEF 14A), proxy filed April 30, 2025
Adage Capital Management, L.P.2,432,000 4.51%Schedule 13G, filed November 13, 2025
Dimensional Fund Advisors1,407,049 2.61%Form 13F, quarter ended March 31, 2025
Alex C. Sapir1,296,449 2.40%Proxy statement (DEF 14A), proxy filed April 30, 2025

Percentages above are of 53,979,306 shares outstanding, as reported by FULCRUM THERAPEUTICS INC. on its Form 10-Q dated April 24, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At FULCRUM THERAPEUTICS INC.'s shareholder meeting held June 26, 2025, in the 2024-2025 proxy season, 125 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 968 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — A non-binding advisory vote on executive compensation; — FULCRUM THERAPEUTICS INC.'s filing reports the proposal as approved, with 99.8% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: FULCRUM THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 27, 2025.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from FULCRUM THERAPEUTICS INC.’s 10-Q dated April 24, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

FULCRUM THERAPEUTICS INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “FULCRUM THERAPEUTICS (FULC) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/fulcrum-therapeutics-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.